Created 3 months ago with the support of Lyon Ingénierie Projet and EZUS Lyon, VirexpR is specialized in the generation of atmospheres contaminated by respiratory viruses or complex mixtures of infectious pathogens in test benches dedicated to the experimental evaluation of air treatment and respiratory protection technologies and devices. This alliance with the TERA Group, a company listed on the stock exchange (Euronext Growth) and internationally recognized as a major player in real-time air quality measurement, will enable VirexpR to significantly consolidate its equity capital and accelerate its international expansion.

We are very proud of this strategic partnership, which reflects recognition of the expertise and technologies developed by Virnext over the last 10 years, and of our ability to exploit them and transfer them to industry. We are very proud to be able to contribute to better control of respiratory viral pathogens and, more generally, to improved indoor air quality, which has major health, economic and societal implications, as well as to the development of French industries and their international competitiveness in the Auvergne-Rhône-Alpes region.